Sees FY25 revenue $2.66B-$2.69B, consensus $2.66B. The company said, “The Company established its full year 2025 revenue guidance range of $2.66 billion to $2.69 billion and fully diluted non-GAAP earnings per share range between $3.40 to $3.50. These preliminary results are unaudited and are based on management’s initial analysis of operations for the periods ended December 31, 2024, and are therefore subject to change. The company expects to announce its fourth quarter and full year 2024 financial results on February 20, 2025, after the market close.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Globus Medical price target raised to $90 from $85 at Truist
- Globus Medical price target raised to $115 from $100 at Roth MKM
- Globus Medical price target raised to $91 from $87 at BTIG
- Globus Medical price target raised to $92 from $85 at Canaccord
- Globus Medical assumed at Overweight from Equal Weight at Morgan Stanley
Questions or Comments about the article? Write to editor@tipranks.com